Schwarz, C. W. (2025) “Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors”, Acta Dermato-Venereologica, 105, p. adv43685. doi: 10.2340/actadv.v105.43685.